Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04636710 | Refining Local-Regional Therapy for IBC | recruiting | N/A | 50 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT06559371 | 68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer | recruiting | — | 150 | Kunwei ShenOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT06645808 | PET-imaging of Two Vartumabs in Patients With Solid Tumors(VARTUTRACE) | recruiting | Early Phase 1 | 32 | Var2 PharmaceuticalsINDUSTRY | 1 | Dec 29, 2025 | clinicaltrials |
| NCT07070778 | Arterial Stiffness in Individuals With Breast Cancer | recruiting | N/A | 18 | Hacettepe UniversityOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT04530890 | Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer | recruiting | N/A | 1,000 | Poitiers University HospitalOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT06022029 | A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.(ON-5001) | recruiting | Phase 1 | 168 | OncoNano Medicine, Inc.INDUSTRY | 2 | Dec 24, 2025 | clinicaltrials |
| NCT06395506 | THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation(THRIVE) | recruiting | N/A | 60 | The University of Texas Medical Branch, GalvestonOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT06666192 | The Ohio State University (OSU) SCREEN Community Program | recruiting | N/A | 2,067 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT04965766 | Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer(ICARUS BREAST) | recruiting | Phase 2 | 139 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT07299812 | BRAVE-HEART: Breast Cancer Radiotherapy Using Active Breathing Coordinator to aVoid Exposure of HEART(BRAVE-HEART) | recruiting | — | 400 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT05817227 | Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.(Selebrec) | recruiting | — | 300 | National Cancer Institute, NaplesOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT06349512 | 68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)(FAP-IT) | recruiting | N/A | 60 | Institut CurieOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT07263451 | Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study | recruiting | N/A | 24 | Tian'an JiangOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT06085274 | Sentinel lympH Node Biopsy With Indocyanine Green in Breast Cancer After NEoadjuvant Chemotherapy (SHINE)(SHINE) | recruiting | N/A | 100 | University Health Network, TorontoOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT06085742 | BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer(BRE-08) | recruiting | Phase 2 | 25 | University of Illinois at ChicagoOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT06498154 | Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy | recruiting | Phase 2 | 200 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT05134779 | De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You(DIGNITY) | recruiting | — | 400 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT06247449 | MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer | recruiting | N/A | 100 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT06774027 | Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer(ENCORE) | recruiting | — | 100 | University of California, San FranciscoOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT07292246 | A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)(ATHENA I) | recruiting | N/A | 15 | Vasileios KallesOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT04722978 | Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer | recruiting | Phase 3 | 228 | Sun Yat-Sen University Cancer CenterOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT05977036 | BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer | recruiting | N/A | 65 | Washington University School of MedicineOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT07014618 | Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer | recruiting | — | 420 | University of OklahomaOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT07122713 | Definitive Radiation Therapy for Inoperable Breast Cancer(DEFINE) | recruiting | N/A | 30 | Alexander StessinOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT04722341 | Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators | recruiting | N/A | 175 | Cedars-Sinai Medical CenterOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT07284030 | Psychoeducation and Well-Being After Breast Cancer(Psychoeducatio) | recruiting | N/A | 72 | Yasemin NazliOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT04563507 | Combined Immunotherapies in Metastatic ER+ Breast Cancer | recruiting | Phase 2 | 102 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT04965064 | Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling | recruiting | Phase 2 | 22 | University of RochesterOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT07281001 | A Study to Assess the Efficiency of Trastuzumab Deruxtecan in Russian Breast Cancer Patients(Traderrus) | recruiting | N/A | 60 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT05142475 | A Study of GC101 TIL in Advanced Breast Cancer (10hospital) | recruiting | Early Phase 1 | 50 | Shanghai Juncell TherapeuticsINDUSTRY | 1 | Dec 11, 2025 | clinicaltrials |
| NCT06107673 | Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC） | recruiting | Phase 2 | 144 | Hebei Medical University Fourth HospitalOTHER | 1 | Dec 11, 2025 | clinicaltrials |
| NCT06375187 | A Study of GC203 TIL in Advanced Malignant Solid Tumors(KUNLUN-001) | recruiting | Phase 1 | 18 | Shanghai Juncell TherapeuticsINDUSTRY | 1 | Dec 11, 2025 | clinicaltrials |
| NCT06582615 | Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer(MIND-TNBC) | recruiting | N/A | 60 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Dec 11, 2025 | clinicaltrials |
| NCT06943521 | A Study of MT-4561 in Patients With Various Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 27 | Tanabe Pharma America, Inc.INDUSTRY | 2 | Dec 11, 2025 | clinicaltrials |
| NCT06961955 | 5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer(FAST NOVEMBER) | recruiting | Phase 2 | 144 | University of UtahOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT06910761 | Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer | recruiting | Phase 2 | 35 | City of Hope Medical CenterOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT07270679 | Genetic Markers of Susceptibility to Chemotherapy-induced Ovarian Damage in Cancer Patients Undergoing Ovarian Biopsy for Cryopreservation. | recruiting | — | 50 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT06238921 | Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases | recruiting | Phase 1 / Phase 2 | 31 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT06731894 | Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors | recruiting | Phase 2 | 120 | City of Hope Medical CenterOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT06817525 | Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC | recruiting | Phase 2 | 64 | Henan Cancer HospitalOTHER_GOV | 1 | Dec 5, 2025 | clinicaltrials |
| NCT06409390 | Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer | recruiting | Phase 2 | 15 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT06946238 | Single-fraction APBI for Early-stage Breast Cancer With Favorable Histological Subtypes (Breast-1F)(Breast-1F) | recruiting | N/A | 311 | IRCCS San RaffaeleOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT03265379 | Improving Quality of Life for Patients With Breast Cancer Invading the Chest Wall: A Prospective Registry For Patients Undergoing Full Thickness Chest Wall Resection | recruiting | — | 104 | University Health Network, TorontoOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT04074720 | Prospective Breast Cancer Biospecimen Collection | recruiting | — | 200 | Thomas Jefferson UniversityOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT05076682 | Reverse Triple Negative Immune Resistant Breast Cancer(Renaissance) | recruiting | Phase 2 | 80 | Fudan UniversityOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT06735131 | The Optimal Radioimmunotherapy Combinations for Advanced TNBC | recruiting | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT07260188 | Organoids From Breast Cancer Patients Treated With Neoadjuvant Therapy(PDO-Neo01) | recruiting | — | 240 | Istituti Clinici Scientifici Maugeri SpAOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT07260591 | VSV-02 Compassionate Use in Advanced Solid Tumors | recruiting | Phase 1 | 6 | The First Affiliated Hospital of Xinxiang Medical CollegeOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT06189209 | Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC) | recruiting | Phase 2 | 40 | Rhizen Pharmaceuticals SAINDUSTRY | 1 | Dec 2, 2025 | clinicaltrials |
| NCT06633380 | Alternative Physical Activity Strategies for Breast Cancer Survivors(PACE) | recruiting | N/A | 24 | University of TorontoOTHER | 1 | Dec 2, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Dec 29, 2025source: clinicaltrials